๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

HOX gene expression in primary and metastatic small cell lung carcinoma

โœ Scribed by C. Cillo; P. Barba; M.F. Poupon; E. Boncinelli

Book ID
119157226
Publisher
Elsevier Science
Year
1991
Weight
187 KB
Volume
27
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hox genes regulation in small-cell lung
Hox genes regulation in small-cell lung cancers
โœ D. Flagiello; B. Malfoy; C. Cillo; B. Dutrillaux; M.F. Poupon ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 86 KB
Hox gene expression in human small-cell
Hox gene expression in human small-cell lung cancers xenografted into nude mice
โœ Claudia Tiberio; Pasquale Barba; Maria Cristina Magli; Francisco Arvelo; Thierry ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 766 KB

## Abstract Transcription factors are crucial to an understanding of the molecular basis of neoplasia. Horneoboxโ€containing genes are a family of transcriptional regulators encoding DNAโ€binding hoโ€meodomains, involved in the control of normal development. Classโ€1 human homeoboxโ€containing genes (__

The 17-1A antigen is expressed on primar
The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells
โœ Bernward Passlick; Wulf Sienel; Rita Seen-Hibler; Werner Wรถckel; Olaf Thetter; K ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 294 KB ๐Ÿ‘ 1 views

In view of the high incidence of early distant tumor relapses in apparently completely resected (R0, M0) non-small cell lung cancer (NSCLC), there is a need for an adjuvant therapy. Considering the low tumor burden in these patients, an adjuvant therapy with monoclonal antibodies (i.e., the 17-1A MA

Chromogranin A gene expression in non-sm
Chromogranin A gene expression in non-small cell lung carcinomas
โœ Abbona, Giancarlo; Papotti, Mauro; Viberti, Laura; Macr??, Luigia; Stella, Anna; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 288 KB ๐Ÿ‘ 2 views

Evidence for the existence of neuroendocrine (NE) differentiation in non-small cell lung carcinomas (NSCLCs) is at present based on histochemical, ultrastructural, and immunohistochemical data. The aim of this study was to investigate the extent of NE differentiation in NSCLCs as revealed by mRNA an